Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs2279256 | chr10:1132852 | G/A | 1.75E-13 | 133 | 42.03 | 70.63 | 17.1 | KM Plot |
| TGCT | rs2291004 | chr19:37997952 | C/A | 1.39E-13 | 134 | 46.3 | 35.37 | 17.1 | KM Plot |
| TGCT | rs2295954 | chr6:15250052 | C/T | 5.56E-5 | 134 | 37.7 | 46.77 | NA | KM Plot |
| TGCT | rs2303131 | chr19:37936025 | G/A | 1.37E-13 | 134 | 45.47 | 37.53 | 17.1 | KM Plot |
| TGCT | rs2320204 | chr17:39366358 | C/T | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs2320205 | chr17:39366360 | G/C | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs2320206 | chr17:39366361 | C/A | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs2320231 | chr17:39340910 | T/C | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs2325847 | chr20:2404050 | G/A | 0.000163 | 134 | 38.2 | 67.22 | 163.3 | KM Plot |
| TGCT | rs2358066 | chr8:116908644 | C/G | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs2387299 | chr10:1163427 | A/G | 1.5E-13 | 133 | 42.1 | 66.9 | 17.1 | KM Plot |
| TGCT | rs2387583 | chr19:49461305 | C/T | 1.02E-5 | 134 | 42.03 | 52.43 | 8 | KM Plot |
| TGCT | rs238789 | chr17:39381582 | A/G | 7.83E-7 | 132 | 13.17 | 56.7 | 42.27 | KM Plot |
| TGCT | rs238792 | chr17:39378852 | G/A | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs238794 | chr17:39375993 | T/A | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |